Booster, COVID-19, CoronaVac, ChAdOx1, vaccine
Dengue control, Community engagement, Vector control strategies, Policy recommendation, Intersectoral collaboration, Risk perception, Vaccine hesitancy
paediatric, HIV, INSTI, bictegravir, tenofovir alafenamide
CoronVac, ChAdOx1, Heath care workers, Thailand, Immunogenicity, Variant of concern
recombinant acellular pertussis vaccine, maternal immunisation, Pregnancy, immunogenicity, safety